Changes to the Code
S. 4440 · Clinical Trial Modernization Act · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
26 U.S.C. § 139J Remuneration provided by sponsors of approved clinical trials to participants New section
1 change the bill asks for here, 1 carried out
- Carried out:
Part III of subchapter B of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting before section 140 the following new section:139J. Remuneration provided by sponsors of approved clinical trials to participants (a) In general.— Gross income shall not include the value of any payment received by an individual from participation in an approved clinical trial (as defined in subsection (d) of the first section 2709 of the Public Health Service Act). (b) Limitation.— The amount excluded from gross income under subsection (a) for any taxable year shall not exceed $2,000..
The section already has a provision under this letter or number, so it would have two.
The Code already has a 26 U.S.C. § 139J, a different section added since this bill was written, so this would be a second section under that number.
§ 139J(a)–(b)
§ 139J. [inserted: Remuneration provided by sponsors of approved clinical trials to participants]
(a) [inserted: In general.—] [inserted: Gross income shall not include the value of any payment received by an individual from participation in an approved clinical trial (as defined in subsection (d) of the first section 2709 of the Public Health Service Act).]
(b) [inserted: Limitation.—] [inserted: The amount excluded from gross income under subsection (a) for any taxable year shall not exceed $2,000.]
42 U.S.C. § 1320a–7b Criminal penalties for acts involving Federal health care programs
3 changes the bill asks for here, 3 carried out
- Carried out:
by striking
and
at the end of subparagraph (K); - Carried out:
by striking the period at the end of subparagraph (L) and inserting
; and
; - Carried out:
by inserting after subparagraph (L) the following new subparagraphs:
(M) any remuneration offered or transferred to an individual while participating in a clinical trial (as defined in subsection (d) of the first section 2709 of the Public Health Service Act) for expenses incurred as part of the trial, other than patient cost-sharing obligations, …
§ 1320a–7b(b)(3)Paragraphs (1) and (2) shall not apply to—(J)–(L)
Start of § 1320a–7b to (b)(3)(I) unchanged ·
(J) a discount in the price of an applicable drug (as defined in paragraph (2) of section 1395w–114a(g) of this title) of a manufacturer that is furnished to an applicable beneficiary (as defined in paragraph (1) of such section) under the Medicare coverage gap discount program under section 1395w–114a of this title;
(K) an incentive payment made to a Medicare fee-for-service beneficiary by an ACO under an ACO Beneficiary Incentive Program established under subsection (m) of section 1395jjj of this title, if the payment is made in accordance with the requirements of such subsection and meets such other conditions as the Secretary may establish;[struck: and]
(L) a bona fide mental health or behavioral health improvement or maintenance program, if—
(i) such program—
§ 1320a–7b(b)–(c)
(b)(3)(L)(i)(I)–(ii)(V) unchanged ·
(VI) any similar entity, as determined by the Secretary; and
(iii) neither the provision of such program, nor the value of such program, are contingent upon the number or value of referrals made by a physician or other clinician to such entity or the amount or value of other business generated by such physician for the entity[struck: .][inserted: ; and]
(M) [inserted: any remuneration offered or transferred to an individual while participating in a clinical trial (as defined in subsection (d) of the first section 2709 of the Public Health Service Act) for expenses incurred as part of the trial, other than patient cost-sharing obligations, including without limitation travel, transportation, and meal expenses, so long as such remuneration is made available to all study participants and facilitates inclusion of patients from all relevant demographic and socioeconomic populations and geographies, including rural communities; and]
(N) [inserted: the free provision to an individual of digital health technologies where—]
(i) [inserted: the use of the digital health technologies is intended to facilitate in any phase of a clinical trial (as so defined) the participation of underrepresented patient populations; and]
(ii) [inserted: the digital health technologies are necessary to such participation.]
(4) Whoever without lawful authority knowingly and willfully purchases, sells or distributes, or arranges for the purchase, sale, or distribution of a beneficiary identification number or unique health identifier for a health care provider under subchapter XVIII, subchapter XIX, or subchapter XXI shall be imprisoned for not more than 10 years or fined not more than $500,000 ($1,000,000 in the case of a corporation), or both.
(c) False statements or representations with respect to condition or operation of institutions Whoever knowingly and willfully makes or causes to be made, or induces or seeks to induce the making of, any false statement or representation of a material fact with respect to the conditions or operation of any institution, facility, or entity in order that such institution, facility, or entity may qualify (either upon initial certification or upon recertification) as a hospital, critical access hospital, skilled nursing facility, nursing facility, intermediate care facility for the mentally retarded, home health agency, or other entity (including an eligible organization under section 1395mm(b) of this title) for which certification is required under subchapter XVIII or a State health care program (as defined in section 1320a–7(h) of this title), or with respect to information required to be provided under section 1320a–3a of this title, shall be guilty of a felony and upon conviction thereof shall be fined not more than $100,000 or imprisoned for not more than 10 years, or both.
Rest of § 1320a–7b unchanged ·
42 U.S.C. § 1320a–7a Civil monetary penalties
The bill's words for this section
- Not carried out:
Section 1128A(i)(6)(F) of the Social Security Act (42 U.S.C. 1320a–7a(i)(6)(F)) is amended by striking under regulations); and inserting the following:
“under regulations, including—(i) remuneration offered or transferred to an individual while participating in a clinical trial, as defined in subsection (d) of the first section 2709 of the Public Health Service Act for expenses incurred as part of the trial, other than patient …
We can't read how this instruction is worded yet, so it isn't shown in the text.
Technical detail
no-pattern: striking QTEXT and inserting the following: “ under regulations, including — QCONTENT.